Virtu KCG Holdings’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$909K Buy
70,942
+43,400
+158% +$580K 0.03% 643
2017
Q1
$357K Sell
27,542
-35,642
-56% -$451K 0.01% 1743
2016
Q4
$624K Buy
63,184
+34,164
+118% +$374K 0.02% 1258
2016
Q3
$351K Buy
+29,020
New +$297K 0.01% 1752
2016
Q2
Sell
-15,695
Closed -$149K 3095
2016
Q1
$149K Buy
15,695
+5,156
+49% +$48.5K ﹤0.01% 2210
2015
Q4
$183K Sell
10,539
-24,124
-70% -$385K ﹤0.01% 2765
2015
Q3
$466K Buy
34,663
+23,616
+214% +$474K 0.01% 1600
2015
Q2
$249K Buy
+11,047
New +$194K ﹤0.01% 2309
2014
Q4
Sell
-26,282
Closed -$239K 3926
2014
Q3
$239K Sell
26,282
-9,894
-27% -$94.2K ﹤0.01% 2678
2014
Q2
$357K Buy
+36,176
New +$307K 0.01% 2343
2014
Q1
Sell
-28,015
Closed -$420K 3725
2013
Q4
$420K Buy
28,015
+4,689
+20% +$60.3K ﹤0.01% 2163
2013
Q3
$257K Buy
+23,326
New +$194K ﹤0.01% 2815

Other funds holding HALO

Virtu KCG Holdings's HALO Position: Q2 2017 in Review

Virtu KCG Holdings increased its Halozyme (HALO) stake by 158% in Q2 2017, buying an estimated $580K and bringing the position to 70,942 shares worth $909K. The position accounts for 0.03% of the portfolio, ranked #643.

Virtu KCG Holdings first reported a position in HALO in Q3 2013 and has held it in 12 quarters since. 167 funds tracked by Wall St. Rank hold HALO as of Q2 2017.

  • Virtu KCG Holdings held 70,942 shares of Halozyme worth $909K as of Q2 2017.
  • Virtu KCG Holdings bought 43,400 Halozyme shares in Q2 2017, an estimated $580K.
  • Halozyme made up 0.03% of Virtu KCG Holdings's portfolio in Q2 2017, its #643 holding.
  • Virtu KCG Holdings first reported a position in Halozyme in Q3 2013 and has held it in 12 quarters since.
  • 167 funds tracked by Wall St. Rank held Halozyme as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.